- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Insight 26 results
Client Alert
August 3, 2021
Biden Administration Issues Proposed Buy American Regulations
Client Alert
July 19, 2021
Trade And Investment In China Headed For More Scrutiny Due To Forced Labor Issues
Client Alert
July 14, 2021
Federal Trade Commission Issues New “Made In USA” Regulations
Client Alert
June 23, 2021
Pharmaceuticals and Active Pharmaceutical Ingredients - Biden Administration Issues 100-Day Supply Chain Review Report
Client Alert
June 15, 2021
High-Capacity Batteries – Biden Administration Issues 100-Day Supply Chain Review Report
Client Alert
June 14, 2021
Critical Minerals And Materials – Biden Administration Issues 100-Day Supply Chain Review Report
Client Alert
June 11, 2021
Semiconductor Manufacturing And Advanced Packaging – Biden Administration Issues 100-Day Supply Chain Review Report
Client Alert
May 18, 2021
President Biden's Executive Order to Improve Cybersecurity Issued
Client Alert
April 26, 2021
Environmental Justice Rises to the Forefront of EPA Policy
Client Alert
April 2, 2021
President Biden Unveils American Jobs Plan
Client Alert
March 26, 2021
Industry-Focused American Rescue Plan Act Summary
Article
March 11, 2021
Biden Administration - What's Ahead for the Life Sciences Industry?